Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy
Activated PI3 kinase delta syndrome (APDS) is a primary immunodeficiency caused by dominant mutations that increase activity of phosphoinositide-3-kinase δ (PI3Kδ). APDS can be caused by mutations in the PIK3CD gene that encodes PI3Kδ catalytic subunit p110δ (APDS1) or mutations in the PIK3R1 gene t...
Main Authors: | David Michalovich, Sergey Nejentsev |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00369/full |
Similar Items
-
Evaluation of Lymphoproliferative Disease and Increased Risk of Lymphoma in Activated Phosphoinositide 3 Kinase Delta Syndrome: A Case Report With Discussion
by: Michele N. Pham, et al.
Published: (2018-12-01) -
Immunodeficiency due to a novel variant in PIK3CD: a case report
by: Niloofar Shashaani, et al.
Published: (2023-07-01) -
The Treatment of Activated PI3Kδ Syndrome
by: Tanya I. Coulter, et al.
Published: (2018-09-01) -
Activated Phosphoinositide 3-Kinase Delta Syndrome 1: Clinical and Immunological Data from an Italian Cohort of Patients
by: Giulio Tessarin, et al.
Published: (2020-10-01) -
Hematopoietic stem cell transplantation
in a patient with activated phosphoinositide
3‑kinase δ syndrome: A case report
and literature review
by: Mateusz P. Łyżwa, et al.
Published: (2023-12-01)